Kuros Biosciences AG (SWX: KURN)

Kuros Biosciences AG Ratios and Metrics

Market cap in millions CHF. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 4, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	633	711	770	489	408	678
Market Cap Growth	-0.55%	-7.77%	57.64%	19.71%	-39.82%	23.22%
Enterprise Value	621	690	774	524	390	695
Last Close Price	16.98	98.77	106.96	67.45	56.34	92.81
PE Ratio	-	-81.56	7.46	30.52	-6.05	49.20
PS Ratio	9.40	1.23	1.23	1.18	1.22	1.76
PB Ratio	5.95	1.77	1.87	1.62	1.44	1.93
P/FCF Ratio	8.84	13.65	7.04	5.34	11.61	9.58
P/OCF Ratio	8.12	12.01	6.57	5.00	10.33	8.78
EV/Sales Ratio	11.82	1.20	1.24	1.26	1.17	1.80
EV/EBITDA Ratio	-21.07	9.64	5.86	15.54	20.30	14.91
EV/EBIT Ratio	-17.03	11.12	6.35	20.94	41.87	20.02
EV/FCF Ratio	-191.28	13.25	7.07	5.72	11.08	9.81
Debt / Equity Ratio	0.09	0.18	0.23	0.31	0.54	0.40
Debt / EBITDA Ratio	-	0.94	0.69	2.36	6.24	2.73
Debt / FCF Ratio	0.42	1.39	0.87	1.01	4.37	2.00
Asset Turnover	0.62	0.91	1.06	0.81	0.60	0.68
Inventory Turnover	2.02	3.01	4.24	6.78	4.30	3.86
Quick Ratio	2.16	1.76	1.14	1.99	1.54	3.20
Current Ratio	3.82	2.66	1.85	2.53	1.94	4.24
Return on Equity (ROE)	-19.31%	-2.12%	28.51%	5.25%	-20.45%	3.69%
Return on Assets (ROA)	-3.96%	6.15%	12.98%	3.06%	1.05%	3.81%
Return on Capital (ROIC)	-4.97%	7.90%	16.88%	3.76%	1.25%	4.51%
Earnings Yield	-1.83%	-1.21%	13.21%	3.14%	-15.83%	1.93%
FCF Yield	-0.51%	7.32%	14.21%	18.72%	8.62%	10.44%
Dividend Yield	1.06%	1.01%	1.87%	1.93%	-	0.65%
Payout Ratio	0.00%	-	-	-	-	84.80%
Buyback Yield / Dilution	-0.34%	-0.39%	-2.34%	-	-0.19%	-0.01%
Total Shareholder Return	-0.34%	0.62%	-0.47%	1.93%	-0.19%	0.64%

Source: S&P Capital IQ. Standard template. Financial Sources.